SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending due to its highly anticipated earnings report, with community discussion polarized between expectations of surging AI revenue and concerns over high valuation and potential post-earnings sell-offs mirroring other recent tech reports.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp ($BULL) is trending as the community eagerly awaits its earnings report, with discussions sharply divided between expectations of a long-overdue reversal fueled by strong fundamentals and perceived undervaluation, and deep skepticism due to consistent past price action and claims of market manipulation in the competitive fintech brokerage sector.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing (RGTI) is seeing significant attention driven by its imminent earnings report, intensifying a sharp divide within the community: bulls are emphasizing new government contracts and a solid cash position for its quantum future, while bears critically point to its high valuation, minimal revenue, and perceived technological delays, anticipating a post-earnings correction.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is surging as a substantial patent settlement removes a major legal overhang, while the FDA's reversal to review its flu vaccine application is driving bullish sentiment and sparking community talk of a massive short squeeze, with attention now turning to its promising oncology pipeline.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is actively trending following its latest earnings report, which, despite an earnings and revenue beat with raised guidance, saw the stock decline due to investor concerns over the lack of fiscal 2027 outlook and broader AI disruption fears within the cybersecurity sector. The community is sharply divided, debating if the sell-off is an overreaction or if the stock will continue its historical underperformance.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending following its recent earnings report, which signaled strong underlying business and sparked intense community debate on its true valuation amidst a one-time factory closure charge. Investors are keenly focused on AMPX's market-leading silicon-anode battery technology and strategic U.S. manufacturing partnerships, positioning it as a critical supplier within the rapidly expanding defense and drone sectors.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending due to escalating geopolitical tensions, which are spotlighting its advanced tactical drone systems, especially the Black Widow, amidst increasing defense sector demand and US Army initiatives. Community discussions center on the anticipation of significant contract awards and a potential short squeeze.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini (GEMI) is sparking significant community discussion after securing a CFTC Designated Contract Market license and launching its prediction market, leading to speculation about a short squeeze and its potential to ride a Bitcoin rally, even as past underperformance raises investor skepticism.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending upward after a Bank of America upgrade to Buy, fueled by optimism for its leadership in consumer autonomy, robotaxis, and the potential of its Optimus humanoid robots and energy segment. This has sparked a divided community discussion, with bulls anticipating further gains and a short squeeze, while bears highlight declining UK sales and perceived market manipulation.

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals is trending strongly on intensifying buyout speculation, fueled by robust OJEMDA sales, a solid cash position, recent preliminary EU approval for its lead drug, and unusual options activity, with the community actively debating potential acquisition valuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Integra LifeSciences (NASDAQ:IART) Stock Price Down 7.7% Following Analyst Downgrade

Integra LifeSciences (NASDAQ:IART) Shares Down 7.7% on Analyst Downgrade...

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Given Consensus Recommendation of "Reduce" by Analysts

Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART - Get Free Report) have been given a consensus rating of "Reduce" by the seven research firms that are covering the company...

Integra Q4 Earnings & Revenues Beat Estimates, Margins Down, Stock Up

IART tops Q4 EPS and revenue estimates despite margin pressure and a sales dip, as shares edge higher and 2026 guidance signals modest growth.

Wells Fargo & Company Issues Pessimistic Forecast for Integra LifeSciences (NASDAQ:IART) Stock Price

Wells Fargo & Company dropped their price target on shares of Integra LifeSciences from $13.00 to $12.00 and set an "equal weight" rating on the stock in a research note on Friday...

Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Integra LifeSciences (NASDAQ:IART) Hits New 12-Month Low - What's Next?

Integra LifeSciences (NASDAQ:IART) Reaches New 1-Year Low - Time to Sell...

Integra LifeSciences Q4 Earnings Call Highlights

Integra LifeSciences (NASDAQ:IART) reported fourth-quarter 2025 results that topped the midpoint of its guidance range, while management emphasized continued progress on quality and supply-chain...

Integra LifeSciences (NASDAQ:IART) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Integra LifeSciences (NASDAQ:IART - Get Free Report) announced its earnings results on Thursday. The life sciences company reported $0.83 EPS for the quarter, topping the consensus estimate of $0.79...

Integra LifeSciences (NASDAQ:IART) Shares Gap Down - What's Next?

Integra LifeSciences (NASDAQ:IART) Shares Gap Down - Here's Why...

Integra (IART) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Integra (IART) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.

IART
Integra Lifesciences Holdings Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest IART News

IARTIntegra Lifesciences Holdings Corp